LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016
LabStyle Innovations Corp, developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the United States in the first quarter of 2016. The national rollout in the U.S. follows the FDA's 510(k) clearance of the Dario in December 2015.
View full press release